ACCO
ACCO Brands Corporation
ACCO has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
ACCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
ACCO's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ACCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $3.97 | -26% |
| Forward | 5.8x | $5.35 | — |
| Current | 7.6x | $5.35 | — |
| Fair | 8.6x | $6.00 | +12% |
| Expensive | 11x | $8.04 | +50% |
Historical ranges are pointers, not guarantees.
ACCO's PE is in its fair range at 7.6x. If earnings grow as analysts expect, today's price would be 5.8x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ACCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ACCO, with profitability holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over ACCO on the outlook, with more favorable profitability expectations.
ACCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.92 | +31% |
| Q3 2026 | $0.70 | +67% |
| Q2 2026 | $0.62 | +32% |
| Q1 2026 | $0.78 | +$1.91 |
| Q4 2025 | $0.44 | +$1.50 |
| Q3 2025 | $0.42 | +$2.30 |
| Q2 2025 | $0.47 | +$2.29 |
| Q1 2025 | -$1.13 | -$0.87 |
| Q4 2024 | -$1.06 | -$0.83 |
ACCO has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ACCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $380.3M | -0.9% |
| Q2 2026 | $415.1M | +5.1% |
| Q1 2026 | $343.7M | +8.3% |
| Q4 2025 | $428.8M | -4.3% |
| Q3 2025 | $383.7M | -8.8% |
| Q2 2025 | $394.8M | -9.9% |
| Q1 2025 | $317.4M | -12% |
| Q4 2024 | $448.1M | -8.3% |
ACCO's revenue fell from its 2021 peak and has held roughly level since: $380M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +1.2 points |
| Q2 2026 | 7.3% | -1.1 points |
| Q1 2026 | -3% | -0.9 points |
| Q4 2025 | 9.3% | 0 points |
| Q3 2025 | 6.8% | +0.5 points |
| Q2 2025 | 8.4% | +34 points |
| Q1 2025 | -2.1% | -3.8 points |
| Q4 2024 | 9.4% | +20 points |
ACCO has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ACCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ACCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $131.4M | +84% |
| Q2 2026 | -$35.3M | +$3.6M |
| Q1 2026 | $3.5M | -36% |
| Q4 2025 | $30.6M | -42% |
| Q3 2025 | $71.5M | -23% |
| Q2 2025 | -$38.9M | -$13.3M |
| Q1 2025 | $5.5M | -80% |
| Q4 2024 | $52.7M | -9.1% |
ACCO has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ACCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +400K shares |
| 1 year | +2.9% | +2.7M shares |
| 3 years | -0.7% | -700K shares |
| 5 years | -1.3% | -1.3M shares |
| Available history | -5% | -5M shares |
ACCO has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $100,000 |
| Q1 2025 | $15M |
| Q4 2024 | $2.5M |
ACCO hasn't bought back shares in the past year.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ACCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.5x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 4.9x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 5.1x | High |
| Q1 2025 | 33.9x | High |
| Q4 2024 | 21.1x | High |
ACCO's net debt is about 4.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 75.7 | Neutral |
ACCO's weekly RSI is 67 (neutral) and its Stochastic is 76 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ACCO PE vs Industrials Sector
| Metric | ACCO | Sector median | Relative |
|---|---|---|---|
| PE | 7.6x | 24x | 68% below |
| PE % | 39 | 58 | 19 pts below |
ACCO is trading at 7.6x earnings, a 68% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ACCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.76 | 12% above |
| 20 week MA | $4.43 | 21% above |
| 50 week MA | $4.01 | 33% above |
| 100 week MA | $4.06 | 32% above |
| 200 week MA | $4.72 | 13% above |
ACCO has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
ACCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.34 | $8.53 | -8.7% |
| 2021 | $8.53 | $8.05 | -5.6% |
| 2022 | $8.05 | $5.58 | -31% |
| 2023 | $5.58 | $6.08 | +9% |
| 2024 | $6.08 | $5.25 | -14% |
| 2025 | $5.25 | $3.73 | -29% |
| 2026 YTD | $3.73 | $5.35 | +43% |
ACCO has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.